Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40WGA | ISIN: GB00BQVXM815 | Ticker-Symbol: 5HU0
Frankfurt
27.06.25 | 08:01
1,720 Euro
+0,58 % +0,010
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HEMOGENYX PHARMACEUTICALS PLC Chart 1 Jahr
5-Tage-Chart
HEMOGENYX PHARMACEUTICALS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
1,7101,95017:42

Aktuelle News zur HEMOGENYX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.06.Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion129THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
17.06.Hemogenyx Pharma Plc - Clearance to Proceed with Pediatric Expansion1
03.06.TRADING UPDATES: Valereum invests in Blubird; Hemogenyx raises funds3
03.06.Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing213THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
03.06.Hemogenyx Pharma Plc - Placing to Raise £451,250 and Director's Dealing1
03.06.Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests146Second Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / June 3, 2025 / Hemogenyx Pharmaceuticals plc is pleased to...
► Artikel lesen
03.06.Hemogenyx Pharma Plc - Second Patient Passes Initial Safety Tests1
HEMOGENYX PHARMACEUTICALS Aktie jetzt für 0€ handeln
30.05.Hemogenyx Pharma Plc - Total Voting Rights-
29.05.Hemogenyx Pharma Plc - Result of AGM-
14.05.Hemogenyx erweitert AML-Studie auf pädiatrische Patienten3
14.05.Hemogenyx expands AML trial to include pediatric patients2
14.05.Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol180Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML LONDON, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to...
► Artikel lesen
14.05.Hemogenyx Pharma Plc - Pediatric Amendment to Clinical Protocol1
13.05.Hemogenyx Pharma Plc - AGM Correction-
08.05.Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing150THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
08.05.Hemogenyx Pharma Plc - Placing to Raise £451,250 and Director's Dealing2
02.05.TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress2
02.05.Hemogenyx Pharma Plc - Notice of AGM-
02.05.Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy268LONDON, GB / ACCESS Newswire / May 2, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that the second patient has been successfully treated as part of the Company's ongoing Phase...
► Artikel lesen
02.05.Hemogenyx Pharma Plc - Second Patient Treated with HG-CT-1 CAR-T Therapy1
Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1